Earnings Call Summary | RECKITT BENCKISER GROUP PLC(RBGPF.US) Q1 2024 Earnings Conference
Earnings Call Summary | RECKITT BENCKISER GROUP PLC(RBGPF.US) Q1 2024 Earnings Conference
The following is a summary of the Reckitt Benckiser Group Plc (RBGPF) Q1 2024 Earnings Call Transcript:
以下是Reckitt Benckiser Group Plc（RBGPF）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
Reckitt Benckiser reported a like-for-like net volume increase of 1.4% across their Hygiene and Health portfolios in Q1 2024.
The Nutrition division experienced a 9.9% decline in net revenue, caused by a negative volume of 9.4% and a 0.5% drop from price/mix.
Hygiene business saw a 7.1% like-for-like net revenue increase, majorly contributed by Finish and Lysol brands.
Health segment saw a 1% increase in like-for-like net revenue led by Durex, Dettol, VMS, and Gaviscon brands.
Reckitt Benckiser's revenue and profit guidance are heavily weighted towards H2, indicating expected margin growth during this period.
Reckitt Benckiser報告稱，2024年第一季度，其衛生與健康投資組合的淨交易量同比增長了1.4％。
營養部門的淨收入下降了9.9％，這是由於9.4％的負交易量和價格/組合下降0.5％造成的。
衛生用品業務淨收入同比增長7.1％，這主要是由Finish和Lysol品牌貢獻的。
在杜蕾斯、滴露、VMS和Gaviscon品牌的帶動下，健康板塊的同比淨收入增長了1％。
Reckitt Benckiser的收入和利潤預期主要集中在下半年，這表明該期間的利潤率有望增長。
Business Progress:
業務進展：
North America saw growth in hygiene brands in Q1 2024, developing markets such as India and China experienced mid-single-digit volume growth.
Reckitt Benckiser's innovations, like Durex Invisible and recently launched Lysol Air Sanitizer, are stimulating growth.
High performing areas such as OTC, Intimate wellness, and Finish will continue to receive investment for continued growth.
The accelerated share buyback program has seen £600 million of shares purchased to date, with another round expected to commence in July.
The company plans to launch new innovations and platforms over the next year, promoting portfolio advancement and shareholder value.
Progress in their strategic agenda is ongoing, with an update expected in their half-year results. Despite being involved in a complex litigation process, Reckitt Benckiser remains committed to its current strategic path.
北美衛生品牌在2024年第一季度實現增長，印度和中國等發展中市場的銷量增長中等個位數。
Reckitt Benckiser的創新，例如杜蕾斯隱形和最近推出的來蘇爾空氣消毒劑，正在刺激增長。
非處方藥、私密健康和芬蘭等表現良好的領域將繼續獲得投資以實現持續增長。
迄今爲止，加速股票回購計劃已購買了6億英鎊的股票，另一輪股票預計將於7月開始。
該公司計劃在明年推出新的創新和平台，促進投資組合的發展和股東價值。
他們的戰略議程正在取得進展，預計將在半年業績中公佈最新情況。儘管參與了複雜的訴訟程序，但Reckitt Benckiser仍然致力於走其當前的戰略道路。
More details: RECKITT BENCKISER GROUP PLC IR
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。